Tag: IBD
Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.
At the start of 2020 the government announced that coverage was changing for people who take Remicade® (infliximab) for the treatment of Crohn’s disease or ulcerative […]
*Disclaimer: How to set goals to Help Manage Inflammatory Bowel Disease (IBD) was submitted by a Ms. Wanni Z. The opinions stated in this article should […]
Are COVID-19 vaccinations in immunocompromised patients with IBD safe? CDHF’s association – the Canadian Association of Gastroenterology (CAG) recently provided guidance for mRNA COVID-19 vaccinations in […]
Please note: This article outlines 11 tips to help you prevent an ulcerative colitis flare, and is based on one patient’s experience. Nothing in this article […]
Good communication with your doctor is an important part of effective management of a gastrointestinal disorder such as IBD. Before your appointment, take the time to […]
Date Written: 09-2020 *This information is intended for educational purposes and is not intended to replace recommendations that have been provided by your Physician and Health […]
If you have recently been diagnosed with Inflammatory Bowel Disease (IBD) – Crohn’s disease or ulcerative colitis, you are likely to set sail on a journey […]
Going back to school, while still only in stage three of COVID-19, is stressful for any parent. However, households that are occupied by someone who is […]
CDHF is SO excited to share Robbie’s Rainbow’s latest edition of “You, Me and IBD” – an educational IBD magazine for children, teens, and parents, in […]
With the spread of COVID-19 we understand it can be even more challenging for patients with IBD to make decisions about navigating life and whether or […]
It’s all over the news, there’s a global pandemic going on and the number one message is to STAY INSIDE! Especially if you’re one of the […]
Making informed decisions is imperative to your good health but understanding the benefits and risks associated with Ulcerative Colitis (UC) treatment options can be challenging. CDHF […]
Making informed decisions is imperative to your good health but understanding the benefits and risks associated with Crohn’s Disease treatment options can be challenging. CDHF developed […]
Deadline date change: The deadline for patients taking a biologic drug to switch to a biosimilar version has been changed from July 1, 2020 to January […]
*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]
Updated March 20201 Having to change any kind of medication can be very stressful. While CDHF believes in patient-physician choice, we acknowledge political policy decisions and […]
Updated March 2021 Having to change any kind of medication can be very stressful. While CDHF believes in patient-physician choice, we acknowledge political policy decisions and […]
*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]
It’s #IBDAwarenessMonth, and to mark the occasion, Effie, Katie and Emma are sharing their advice for Canadians living with #ulcerativecolitis. Here’s how you can live your […]
*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]
*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]
Helping inflammatory bowel disease (IBD) patients best understand transitioning/switching from a reference biologic to a biosimilar.
*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]
Patient Survey BC PharmaCare and Alberta Health coverage is changing for people who take Remicade® (infliximab) for the treatment of Crohn’s disease or ulcerative colitis. In […]
CDHF is Canada’s trusted source for timely information on the BC Biosimilars Initiative What’s Changing? Since its launch, the Initiative has successfully switched many PharmaCare patients […]
Hot off the Presses: The Latest IBD Information from Scientific Meetings with Dr. Silverberg Webinar
In this educational webinar, Dr. Silverberg reviewed the most recent scientific findings in Inflammatory Bowel Disease (IBD) and discussed the role of diet and gut bacteria […]
In this educational webinar, Dr. Silverberg reviewed the most recent scientific findings in Inflammatory Bowel Disease (IBD) and discussed the role of diet and gut bacteria […]
On June 26th CDHF sat down with three individuals who have been diagnosed with ulcerative colitis (UC) to learn all about what it is like to […]
On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars: What’s the difference between a reference biologic drug and […]
On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars: What’s the difference between a reference biologic drug […]
This empowering session reviewed the basics of IBD, outlined the benefits and risks of medications used to treat ulcerative colitis and Crohn’s disease and answered the […]
This empowering session reviewed the basics of IBD, outlined the benefits and risks of medications used to treat ulcerative colitis and Crohn’s disease and answered the […]
[iframe_loader type=’iframe’ width=’100%’ height=’600′ frameborder=’0′ scrolling=’no’ src=’/wp-content/uploads/articulate_uploads/IBD-Benefits-and-Risk-Assesment-Tool/story.html’] Making informed decisions is imperative to your good health but understanding the benefits and risks associated with IBD therapy […]
